Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy ; day:5 ; month:3 ; year:2021 ; pages:1-15
Cancer immunology immunotherapy ; (5.3.2021), 1-15
- Urheber
-
Wenthe, Jessica
Naseri, Sedigheh
Labani-Motlagh, Alireza
Enblad, Gunilla
Wikström, Kristina I.
Eriksson, Emma
Loskog, Angelica
Lövgren, Tanja
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-021-02895-7
- URN
-
urn:nbn:de:101:1-2021041820284778873331
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wenthe, Jessica
- Naseri, Sedigheh
- Labani-Motlagh, Alireza
- Enblad, Gunilla
- Wikström, Kristina I.
- Eriksson, Emma
- Loskog, Angelica
- Lövgren, Tanja
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
Viral Oncolytic Therapy
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Author Correction: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
Viral Oncolytic Therapy
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Author Correction: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
Viral Oncolytic Therapy
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis